Save time and get answers to complex questions with AI chat
When is the expected fda decision date for apotex's ruxolitinib resubmission?Patent term adjustment semaglutida?Norcuron generic name?When did risperdal constas patent expire published article?When will there be a generic loreev available?
See the DrugPatentWatch profile for Acetazolamide
Acetazolamide is a carbonic anhydrase inhibitor. It belongs to the class of medications that block the enzyme carbonic anhydrase, which reduces the production of bicarbonate in the body and changes how the kidneys handle acid-base balance and electrolytes.
Because it inhibits carbonic anhydrase, acetazolamide can: - act as a mild diuretic (it increases bicarbonate loss, which can lead to changes in urine output), - cause a metabolic acidosis effect (from altered acid-base handling), - be used for conditions linked to fluid pressure and electrolyte/acid-base changes, including certain eye and altitude-related uses.
It is sometimes described as a diuretic, but more specifically it is classified by its mechanism as a carbonic anhydrase inhibitor (the drug class).
Other Questions About Acetazolamide :